Enovis (ENOV) Competitors

Penumbra (NYSE:PEN) and Enovis (NYSE:ENOV) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Do analysts rate PEN or ENOV?

Penumbra presently has a consensus target price of $258.00, indicating a potential downside of 2.30%. Enovis has a consensus target price of $67.00, indicating a potential upside of 43.52%. Given Enovis' stronger consensus rating and higher probable upside, analysts clearly believe Enovis is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	4 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.80
Enovis	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

Does the MarketBeat Community prefer PEN or ENOV?

Penumbra received 790 more outperform votes than Enovis when rated by MarketBeat users. Likewise, 80.29% of users gave Penumbra an outperform vote while only 61.70% of users gave Enovis an outperform vote.

Company	Underperform	Outperform
Penumbra	Outperform Votes 819 80.29%	Underperform Votes 201 19.71%
Enovis	Outperform Votes 29 61.70%	Underperform Votes 18 38.30%

Which has preferable valuation & earnings, PEN or ENOV?

Penumbra has higher earnings, but lower revenue than Enovis. Enovis is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.06B	9.58	$90.95M	$0.86	307.07
Enovis	$1.71B	1.53	-$33.26M	-$2.19	-21.32

Does the media refer more to PEN or ENOV?

In the previous week, Enovis had 6 more articles in the media than Penumbra. MarketBeat recorded 9 mentions for Enovis and 3 mentions for Penumbra. Penumbra's average media sentiment score of 0.50 beat Enovis' score of 0.41 indicating that Penumbra is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Enovis	4 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders & institutionals believe in PEN or ENOV?

88.9% of Penumbra shares are held by institutional investors. Comparatively, 98.5% of Enovis shares are held by institutional investors. 5.0% of Penumbra shares are held by insiders. Comparatively, 2.4% of Enovis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Which has more volatility and risk, PEN or ENOV?

Penumbra has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500. Comparatively, Enovis has a beta of 1.94, indicating that its share price is 94% more volatile than the S&P 500.

Is PEN or ENOV more profitable?

Penumbra has a net margin of 2.97% compared to Enovis' net margin of -5.95%. Penumbra's return on equity of 8.99% beat Enovis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	2.97%	8.99%	6.80%
Enovis	-5.95%	4.39%	2.80%

Summary

Penumbra beats Enovis on 13 of the 19 factors compared between the two stocks.